3Olbricht CJ,Koch KM. Treatment of hyperlipidemia in nephritic syndrome :time for a change [J]. Nephron, 1992, 62 (2) :125-- 129.
4Nauita I, Saito N, Goto S, et al. Role of uteroglobin G38A polymorphism in the progression of lgA nephropathy in Japanese patients[J]. Kidney Int.2002,61(5): 1853～1858.
5Szelestei T, Bahring S, Kovacs T, et al. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy [J].Am J Kidney Dis. 2000,36(3):468～473.
6Kim YS, Kang D, Kwon DY, et al. Uteroglobin gene polymorphisms affect the progression of immunoglobulin a nephropathy by modulating the level of u teroglobin expression [J]. Pharmacogenetics. 2001,11 (4): 299～305.
7Hsu SI, Ramirez SB, Winn MP,et al. Evidence for genetic factors in the development and progression of IgA nephropathy[J] . Kidney Int, 2000,57(5) : 1818 - 1835.
8Akiyama F, Tanaka T, Yamada R, et al. Single-nucleotide polymorphisms in the class Ⅱ region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy[J] .J Hum Genet.2002,47(10) :532～538.
9Matthews VB, Witt CS, French MA,et al. Central MHC genes affect IgA levels in the human: reciprocal effects in IgA deficiency and IgA nephropathy[J] .Hum Immunol. 2002,63(5) :424～433.
10Li PK, Poon P, Phil M,et al. Association of lgA nephropathy with T-cell receptor constant alpha chain gene polymorhism[J]. Am J Kidney Dis.1997,30(2) :260～264.
